2008 Fall - Open Innovation

Open Innovation

• Open Innovation and the Health Commons – Marty Tenenbaum
• Open Innovation in Pharma – John Reynders, Johnson & Johnson
• Using IP to Identify and Evaluate Open Innovation Partners – John Cronin, ipCapital Group

Panel: Enabling Open Innovation in Pharma

• Susie Stephens, Eli Lilly (Moderator)
• Jason Hwang, Innosight
• Sanjoy Ray, Merck
• Danny Weitzner, W3C

Panel: Innovation Models – Perspectives and Discussion

• Robin McEntire (Moderator)
• Kevin Hebbel, Pfizer
• Bruce Ackman, Innocentive
• Lorrie LeJeune , Open WetWare